Home   Partnering   Investors   Contact 

"Improving Nature"   

QuantiBact is developing a technology that will significantly improve molecular diagnostics in the near future.

QuantiBact A/S is a biotech company founded on research regarding nucleic acid analogues performed at Syddansk Universitet and Hvidovre Hospital.

We are developing diagnostic tools for the detection of infectious diseases by: increasing specificity, minimizing turn-around time and increasing fidelity of quantification. Our technology will significantly improve hybridization and PCR based assays.

info@quantibact.com